查看分析师 EPS 与营收区间、覆盖人数，以及过去 7、30、90 天的预期变化。缺失修正不会显示成零；分析师人数较少的公司默认不进入排名。
| 公司 | 财年 EPS | 预期区间 | 分析师 | 7 日 | 30 日 | 90 日 | 30 日上调 / 下调 | 营收预期 |
|---|---|---|---|---|---|---|---|---|
| MPC Marathon Petroleum Corporation Common Stock | 39.08 2026-12-31 | 22.09 – 58.5 | 15 | +7.78% | +31.59% | +72.34% | 4 / 2 | $152.43B |
| REGN Regeneron Pharmaceuticals Inc. Common Stock | 52.6 2026-12-31 | 43.42 – 59.45 | 28 | +14.72% | +13.82% | +13.43% | 0 / 1 | $16.9B |
| WY Weyerhaeuser Company Common Stock | 0.33 2026-12-31 | 0.28 – 0.38 | 8 | +17.78% | +10.67% | +22.10% | 0 / 1 | $7.13B |
| PTGX Protagonist Therapeutics Inc. Common Stock | 4.47 2026-12-31 | 2.05 – 6.03 | 12 | +6.73% | +7.05% | +61.06% | 6 / 2 | $529.83M |
| TVTX Travere Therapeutics Inc. Common Stock | 1.97 2026-12-31 | 0.92 – 2.86 | 7 | +4.87% | +5.35% | +17.05% | 2 / 2 | $679.11M |
| WST West Pharmaceutical Services Inc. Common Stock | 8.96 2026-12-31 | 8.83 – 9.05 | 16 | +0.07% | +4.04% | +3.92% | 1 / 1 | $3.37B |
| NESR National Energy Services Reunited Corp Ordinary Shares | 1.71 2026-12-31 | 1.6 – 1.86 | 7 | +2.80% | +3.48% | +11.82% | 2 / 0 | $1.9B |
| BUD Anheuser-Busch Inbev SA Sponsored ADR (Belgium) | 4.51 2026-12-31 | 4.44 – 4.63 | 7 | +2.81% | +2.62% | +5.15% | 2 / 2 | $64.71B |
| TGTX TG Therapeutics Inc. Common Stock | 1.57 2026-12-31 | 1.3 – 1.82 | 6 | -2.51% | +2.42% | +33.73% | 2 / 0 | $942.51M |
| LGND Ligand Pharmaceuticals Incorporated Common Stock | 9.18 2026-12-31 | 8.79 – 9.68 | 8 | +0.30% | +0.91% | +6.33% | 2 / 2 | $289.77M |
| ZVRA Zevra Therapeutics Inc. Common Stock | 1.23 2026-12-31 | 1.19 – 1.31 | 3 | +0.82% | +0.82% | +148.53% | 1 / 0 | $145.72M |
| INDV Indivior Pharmaceuticals Inc. Common Stock | 3.85 2026-12-31 | 3.63 – 4.05 | 5 | +0.78% | +0.78% | +23.49% | 4 / 0 | $1.26B |
| AMRX Amneal Pharmaceuticals Inc. Class A Common Stock | 0.99 2026-12-31 | 0.94 – 1.03 | 5 | +1.43% | +0.64% | -0.35% | 2 / 1 | $3.14B |
| COLL Collegium Pharmaceutical Inc. Common Stock | 7.76 2026-12-31 | 7.29 – 8.18 | 4 | +0.58% | +0.58% | +5.19% | 4 / 1 | $869.86M |
| ANIP ANI Pharmaceuticals Inc. | 9.42 2026-12-31 | 9.19 – 9.68 | 8 | +0.11% | +0.58% | +3.83% | 7 / 0 | $1.12B |
| LNTH Lantheus Holdings Inc. Common Stock | 5.36 2026-12-31 | 5.15 – 5.84 | 13 | -0.21% | +0.42% | +3.21% | 12 / 0 | $1.47B |
| KDP Keurig Dr Pepper Inc. Common Stock | 2.29 2026-12-31 | 2.26 – 2.32 | 18 | -0.01% | +0.15% | +0.19% | 1 / 0 | $26.26B |
| CCEP Coca-Cola Europacific Partners plc Ordinary Shares | 4.46 2026-12-31 | 4.39 – 4.56 | 9 | +0.01% | +0.01% | +0.21% | 1 / 2 | $21.53B |
| SUPN Supernus Pharmaceuticals Inc. Common Stock | 2.49 2026-12-31 | 2.11 – 2.95 | 3 | 0.00% | 0.00% | +6.27% | 0 / 0 | $867.18M |
| BMRN BioMarin Pharmaceutical Inc. Common Stock | 4.93 2026-12-31 | 4.86 – 5.03 | 17 | -0.10% | -0.05% | -7.84% | 1 / 0 | $3.87B |
| TRI Thomson Reuters Corporation Common Shares | 4.41 2026-12-31 | 4.13 – 4.55 | 17 | -0.04% | -0.25% | -1.35% | 1 / 2 | $8.08B |
| JAZZ Jazz Pharmaceuticals plc Common Stock (Ireland) | 25.31 2026-12-31 | 24.38 – 26.99 | 17 | 0.00% | -0.32% | +5.08% | 0 / 1 | $4.51B |
| HALO Halozyme Therapeutics Inc. Common Stock | 8.1 2026-12-31 | 7.91 – 8.21 | 6 | -0.10% | -0.50% | +0.15% | 3 / 1 | $1.77B |
| RIGL Rigel Pharmaceuticals Inc. Common Stock | 2.89 2026-12-31 | 0.64 – 4.01 | 4 | -0.77% | -0.77% | -39.72% | 0 / 1 | $278.89M |
| NBIX Neurocrine Biosciences Inc. Common Stock | 10.1 2026-12-31 | 8.7 – 11.28 | 17 | +1.45% | -0.86% | +4.80% | 1 / 0 | $3.9B |
| VRTX Vertex Pharmaceuticals Incorporated Common Stock | 18.98 2026-12-31 | 17.61 – 19.85 | 20 | +0.09% | -0.86% | -0.56% | 14 / 10 | $13.05B |
| SRPT Sarepta Therapeutics Inc. Common Stock (DE) | 4.79 2026-12-31 | 3.45 – 6.3 | 11 | -0.60% | -0.92% | +19.83% | 0 / 1 | $1.84B |
| AUPH Aurinia Pharmaceuticals Inc Ordinary Shares | 0.95 2026-12-31 | 0.85 – 1.04 | 5 | -1.04% | -1.04% | +21.28% | 1 / 0 | $325.82M |
| UTHR United Therapeutics Corporation Common Stock | 26.92 2026-12-31 | 24.93 – 29.43 | 14 | +0.27% | -1.44% | -5.20% | 0 / 1 | $3.24B |
| EEFT Euronet Worldwide Inc. Common Stock | 10.77 2026-12-31 | 10.58 – 11.07 | 8 | -1.43% | -1.87% | -1.57% | 8 / 1 | $4.47B |
| KNSA Kiniksa Pharmaceuticals International plc Class A Ordinary Shares | 1.16 2026-12-31 | 1.07 – 1.23 | 4 | -0.22% | -3.54% | -1.91% | 0 / 0 | $993.71M |
| TEVA Teva Pharmaceutical Industries Limited American Depositary Shares | 2.14 2026-12-31 | 1.91 – 2.94 | 12 | -0.78% | -3.63% | -10.64% | 0 / 4 | $16.58B |
| ACAD ACADIA Pharmaceuticals Inc. Common Stock | 0.37 2026-12-31 | 0.27 – 0.51 | 13 | 0.00% | -4.07% | -24.73% | 0 / 1 | $1.24B |
| AMPH Amphastar Pharmaceuticals Inc. Common Stock | 2.56 2026-12-31 | 2.26 – 2.87 | 7 | -2.64% | -4.61% | -21.31% | 0 / 1 | $745.19M |
| ALNY Alnylam Pharmaceuticals Inc. Common Stock | 8.95 2026-12-31 | 7.77 – 10.71 | 15 | -5.05% | -5.02% | -3.47% | 0 / 1 | $5.51B |
| LEU Centrus Energy Corp. Class A Common Stock | 3.88 2026-12-31 | 2.72 – 4.55 | 4 | -2.43% | -6.68% | +3.13% | 0 / 0 | $459.33M |
| OXY Occidental Petroleum Corporation Common Stock | 5.44 2026-12-31 | 4.32 – 7.19 | 21 | -0.50% | -8.14% | +24.67% | 3 / 2 | $24.72B |
| CDE Coeur Mining Inc. Common Stock | 1.52 2026-12-31 | 1.06 – 2.08 | 9 | -6.89% | -13.56% | -29.92% | 1 / 2 | $4.97B |
| AARD Aardvark Therapeutics Inc. Common Stock | -3.67 2026-12-31 | -4.4 – -2.83 | 9 | — | — | — | 0 / 7 | $0 |
| ABEO Abeona Therapeutics Inc. Common Stock | -0.68 2026-12-31 | -0.95 – -0.45 | 3 | — | — | — | 0 / 3 | $65.51M |
| ABOS Acumen Pharmaceuticals Inc. Common Stock | -1.58 2026-12-31 | -1.76 – -1.32 | 3 | — | — | — | 2 / 0 | $0 |
| ACRS Aclaris Therapeutics Inc. Common Stock | -0.66 2026-12-31 | -0.79 – -0.49 | 8 | — | — | — | 2 / 2 | $5.71M |
| ACRV Acrivon Therapeutics Inc. Common Stock | -2.07 2026-12-31 | -2.5 – -1.68 | 7 | — | — | — | 3 / 2 | $0 |
| ACTU Actuate Therapeutics Inc. Common stock | -0.78 2026-12-31 | -0.84 – -0.67 | 3 | — | — | — | 1 / 2 | $0 |
| ADCT ADC Therapeutics SA Common Shares | -0.86 2026-12-31 | -0.91 – -0.78 | 5 | — | — | — | 1 / 1 | $80.89M |
| AGIO Agios Pharmaceuticals Inc. Common Stock | -5.66 2026-12-31 | -6.49 – -4.75 | 7 | — | — | — | 0 / 1 | $179.38M |
| AGMB AgomAb Therapeutics NV American Depositary Shares | -1.95 2026-12-31 | -2.34 – -1.62 | 4 | — | — | — | 1 / 1 | $0 |
| ALDX Aldeyra Therapeutics Inc. Common Stock | -0.3 2026-12-31 | -0.43 – -0.22 | 4 | — | — | — | 3 / 0 | $1.25M |
| ALGS Aligos Therapeutics Inc. Common Stock | -7.11 2026-12-31 | -11.76 – -2.65 | 6 | — | — | — | 1 / 1 | $21.68M |
| ALLO Allogene Therapeutics Inc. Common Stock | -0.61 2026-12-31 | -0.66 – -0.58 | 5 | — | — | — | 2 / 1 | $6.67K |
| AMLX Amylyx Pharmaceuticals Inc. Common Stock | -1.43 2026-12-31 | -1.59 – -1.27 | 7 | — | — | — | 3 / 4 | $0 |
| ANRO Alto Neuroscience Inc. Common Stock | -3.15 2026-12-31 | -3.72 – -2.58 | 6 | — | — | — | 0 / 1 | $0 |
| APGE Apogee Therapeutics Inc. Common Stock | -4.41 2026-12-31 | -5 – -3.25 | 12 | — | — | — | 3 / 0 | $9.09M |
| APRE Aprea Therapeutics Inc. Common stock | -0.83 2026-12-31 | -0.93 – -0.66 | 3 | — | — | — | 1 / 0 | $535K |
| ARCT Arcturus Therapeutics Holdings Inc. Common Stock | -3.86 2026-12-31 | -5.61 – -1.28 | 11 | — | — | — | 4 / 5 | $22M |
| ARQT Arcutis Biotherapeutics Inc. Common Stock | 0.18 2026-12-31 | -0.05 – 0.33 | 6 | — | — | -38.47% | 1 / 2 | $500.09M |
| ARTV Artiva Biotherapeutics Inc. Common Stock | -2.43 2026-12-31 | -2.67 – -2.18 | 4 | — | — | — | 1 / 0 | $0 |
| ARWR Arrowhead Pharmaceuticals Inc. Common Stock | -3.11 2026-09-30 | -3.82 – -1.85 | 11 | — | — | — | 2 / 0 | $438.76M |
| AUTL Autolus Therapeutics plc American Depositary Share | -0.89 2026-12-31 | -1.24 – -0.56 | 8 | — | — | — | 6 / 1 | $128.58M |
| AVTX Avalo Therapeutics Inc. Common Stock | -2.56 2026-12-31 | -3.53 – -1.77 | 11 | — | — | — | 5 / 0 | $0 |
| AXSM Axsome Therapeutics Inc. Common Stock | -1.82 2026-12-31 | -3.35 – 1.3 | 11 | — | — | — | 1 / 5 | $979.08M |
| BBOT BridgeBio Oncology Therapeutics Inc. Common Stock | -2.21 2026-12-31 | -2.72 – -1.72 | 10 | — | — | — | 0 / 1 | $0 |
| BCAX Bicara Therapeutics Inc. Common Stock | -3.48 2026-12-31 | -4.08 – -2.52 | 13 | — | — | — | 0 / 11 | $0 |
| BCYC Bicycle Therapeutics plc American Depositary Shares | -2.58 2026-12-31 | -2.8 – -2.13 | 6 | — | — | — | 1 / 8 | $16.42M |
| BDTX Black Diamond Therapeutics Inc. Common Stock | -0.63 2026-12-31 | -0.96 – -0.1 | 6 | — | — | — | 2 / 3 | $5.56M |
| BEAM Beam Therapeutics Inc. Common Stock | -4.43 2026-12-31 | -4.76 – -3.8 | 13 | — | — | — | 7 / 5 | $78.87M |
| BOLT Bolt Biotherapeutics Inc. Common Stock | -238.28 2026-12-31 | -686 – -11.1 | 3 | — | — | — | 0 / 0 | $1.51M |
| CADL Candel Therapeutics Inc. Common Stock | -0.9 2026-12-31 | -1.11 – -0.74 | 4 | — | — | — | 0 / 0 | $0 |
| CAMP CAMP4 Therapeutics Corporation Common Stock | -0.79 2026-12-31 | -0.97 – -0.68 | 3 | — | — | — | 0 / 1 | $6.28M |
| CAPR Capricor Therapeutics Inc. Common Stock | -1.05 2026-12-31 | -2.43 – 1.7 | 9 | — | — | — | 2 / 4 | $64.76M |
| CATX Perspective Therapeutics Inc. Common Stock | -1.12 2026-12-31 | -1.37 – -0.96 | 8 | — | — | — | 4 / 1 | $423.17K |
| CCCC C4 Therapeutics Inc. Common Stock | -0.96 2026-12-31 | -1.06 – -0.83 | 5 | — | — | — | 3 / 0 | $18.93M |
| CGEM Cullinan Therapeutics Inc. Common Stock | -3 2026-12-31 | -3.54 – -1.76 | 9 | — | — | — | 0 / 1 | $17.85M |
| CGTX Cognition Therapeutics Inc. Common Stock | -0.34 2026-12-31 | -0.44 – -0.26 | 3 | — | — | — | 3 / 1 | $0 |
| CLDX Celldex Therapeutics Inc. | -4.35 2026-12-31 | -4.57 – -3.95 | 11 | — | — | — | 6 / 0 | $2.42M |
| CLPT ClearPoint Neuro Inc. Common Stock | -1.11 2026-12-31 | -1.24 – -1.01 | 3 | — | — | — | 0 / 2 | $53.13M |
| CMPX Compass Therapeutics Inc. Common Stock | -0.43 2026-12-31 | -0.59 – -0.33 | 12 | — | — | — | 1 / 2 | -$2.06M |
| CNTX Context Therapeutics Inc. Common Stock | -0.39 2026-12-31 | -0.43 – -0.3 | 8 | — | — | — | 6 / 1 | $0 |
| COAG Hemab Therapeutics Holdings Inc. Common Stock | -3.06 2026-12-31 | -3.59 – -2.48 | 3 | — | — | — | 0 / 0 | $0 |
| COYA Coya Therapeutics Inc. Common Stock | -1.48 2026-12-31 | -1.52 – -1.42 | 4 | — | — | — | 1 / 1 | $2.35M |
| CRBP Corbus Pharmaceuticals Holdings Inc. Common Stock | -4.57 2026-12-31 | -5.7 – -3.31 | 10 | — | — | — | 4 / 4 | $1.11M |
| CRDL Cardiol Therapeutics Inc. Class A Common Shares | -0.36 2026-12-31 | -0.49 – -0.25 | 4 | — | — | — | 1 / 2 | $0 |
| CRNX Crinetics Pharmaceuticals Inc. Common Stock | -4.62 2026-12-31 | -5.28 – -3.48 | 13 | — | — | — | 0 / 1 | $68.49M |
| CRSP CRISPR Therapeutics AG Common Shares | -4.86 2026-12-31 | -6.37 – -3.35 | 19 | — | — | — | 1 / 2 | $42.21M |
| CRVS Corvus Pharmaceuticals Inc. Common Stock | -0.71 2026-12-31 | -0.8 – -0.65 | 4 | — | — | — | 0 / 3 | $0 |
| CTMX CytomX Therapeutics Inc. Common Stock | -0.42 2026-12-31 | -0.51 – -0.34 | 6 | — | — | — | 2 / 4 | $35.75M |
| CTNM Contineum Therapeutics Inc. Class A Common Stock | -1.56 2026-12-31 | -1.83 – -0.96 | 7 | — | — | — | 7 / 0 | $6.88M |
| DFTX Definium Therapeutics Inc. Common Shares | -2.2 2026-12-31 | -2.67 – -1.85 | 13 | — | — | — | 2 / 2 | $0 |
| DMAC DiaMedica Therapeutics Inc. Common Stock | -0.83 2026-12-31 | -0.9 – -0.76 | 4 | — | — | — | 2 / 2 | $0 |
| DMRA Damora Therapeutics Inc. Ordinary Shares | -1.76 2026-12-31 | -2.32 – -1.26 | 4 | — | — | — | 1 / 0 | $0 |
| DNLI Denali Therapeutics Inc. Common Stock | -2.37 2026-12-31 | -2.97 – -1.21 | 15 | — | — | — | 11 / 2 | $33.97M |
| DNTH Dianthus Therapeutics Inc. Common Stock | -3.93 2026-12-31 | -5.06 – -3.44 | 9 | — | — | — | 5 / 1 | $1.21M |
| DSGN Design Therapeutics Inc. Common Stock | -1.36 2026-12-31 | -1.63 – -1.17 | 7 | — | — | — | 3 / 2 | $0 |
| DYN Dyne Therapeutics Inc. Common Stock | -3.53 2026-12-31 | -3.94 – -3.16 | 11 | — | — | — | 7 / 6 | $0 |
| EIKN Eikon Therapeutics Inc. Common Stock | -6.35 2026-12-31 | -6.82 – -5.35 | 5 | — | — | — | 1 / 2 | $0 |
| ELDN Eledon Pharmaceuticals Inc. Common Stock | -0.87 2026-12-31 | -0.92 – -0.77 | 4 | — | — | — | 2 / 0 | $0 |
| ELTX Elicio Therapeutics Inc. Common Stock | -2.07 2026-12-31 | -2.3 – -1.82 | 4 | — | — | — | 1 / 0 | $0 |
| ELVN Enliven Therapeutics Inc. Common Stock | -1.7 2026-12-31 | -1.84 – -1.37 | 4 | — | — | — | 0 / 0 | $0 |
| ENGN enGene Therapeutics Inc. Common Stock | -1.73 2026-10-31 | -1.95 – -1.56 | 9 | — | — | — | 9 / 0 | $0 |
| ENTA Enanta Pharmaceuticals Inc. Common Stock | -1.88 2026-09-30 | -2.27 – -1.39 | 4 | — | — | — | 2 / 1 | $66.34M |
默认至少 3 位分析师。没有历史值、EPS 非正值或历史 EPS 过于接近零时显示“—”，不会用失真的百分比参与排名。
榜单优先使用当前财年 EPS；营收修正由每日快照逐步积累，首日不会生成伪历史。